The LIF receptor complex, composed of LIF, LIFR, and glycoprotein 130 (gp130), is responsible for promoting tumor growth, progression, and metastasis through the direct effect of JAK/STAT3 and other downstream pathways, such as MAPK, AKT, and mTOR [54]. The gene discussed is LIFR; the disease is neoplasm.